Late gadolinium enhancement following Covid-19 infection does not predict outcome: a single-centre study.

Back

ESC Professional Premium Access

Late gadolinium enhancement following Covid-19 infection does not predict outcome: a single-centre study.

Session: CMR tissue characterisation: why it matters

Topic: Late Gadolinium Enhancement

Speaker: Doctor K. Vimalesvaran (London, GB)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Kavitha Vimalesvaran

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

1 follower

7 more presentations in this session

Prognostic value of left ventricular hypertrophy in patients with myocardial fibrosis by ECV mapping on cardiac MRI

Speaker: Doctor L. Alam (New York City, US)

Risk stratification in patients with structurally normal hearts: does fibrosis type matter?

Speaker: Assistant Professor K. Gil (Columbus, US)

Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging

Speaker: Doctor M. Paus (Oslo, NO)

Left ventricular fibrosis influences the time to recovery in patients with arrhythmia-induced cardiomyopathy

Speaker: Doctor D. Lavall (Leipzig, DE)

Association of late-gadolinium enhancement on cardiac magnetic resonance with cardiovascular outcomes and mortality in patients with aortic stenosis

Speaker: Doctor S. Moussa (Stony Brook, US)

Access the full session

CMR tissue characterisation: why it matters

Speakers: Doctor K. Vimalesvaran, Doctor L. Alam, Assistant Professor K. Gil, Doctor M. Paus, Doctor D. Lavall...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources